Replies to post #65061 on Biotech Values

[DewDiligence]

VRUS – Data from the 500mg BID and 1500mg BID cohorts of this study were reported in April (#msg-28837612). What’s new in today’s PR are preliminary data from the 1000mg BID cohort. Data from a fourth cohort (1500mg BID in treatment-refractory gentotype-2/3) have not yet been reported.